Isis Pharmaceuticals Heavy Put Volume May be Attributed to Seeking Alpha Article on Company's Cholesterol Drug
A spokesperson for Isis Pharmaceuticals (NASDAQ: ISIS) says she is aware of Seeking Alpha article comparing Isis' cholesterol reducing drug Mipomersen (Kynamro) with Aegerion Pharmaceuticals' (NASDAQ: AEGR) Lomitapide.
Mipromersen's PDUFA date is January 29, 2013.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.